AKBA (STOCKS)
Akebia Therapeutics, Inc.
$1.450000
+0.050000 (+3.57%)
Prev close: $1.400000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- John P. Butler
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $392.44M
- Employees
- 181
- P/E (TTM)
- -77.78
- P/B (TTM)
- 11.40
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $236.20M |
| Benefits Costs and Expenses | $239.92M |
| Cost Of Revenue | $39.46M |
| Costs And Expenses | $239.92M |
| Gross Profit | $196.73M |
| Operating Expenses | $173.24M |
| Selling, General, and Administrative Expenses | $107.48M |
| Research and Development | $62.36M |
| Other Operating Expenses | $3.40M |
| Operating Income/Loss | $23.50M |
| Income/Loss From Continuing Operations After Tax | -$5.35M |
| Income/Loss From Continuing Operations Before Tax | -$3.72M |
| Income Tax Expense/Benefit | $1.62M |
| Income Tax Expense/Benefit, Current | $1.62M |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$5.35M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$5.35M |
| Net Income/Loss Available To Common Stockholders, Basic | -$5.35M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.02 |
| Diluted Earnings Per Share | -$0.02 |
| Basic Average Shares | 257,157,782 |
| Diluted Average Shares | 257,157,782 |
| Assets | $376.57M |
| Current Assets | $252.96M |
| Inventory | $15.61M |
| Prepaid Expenses | $0.00 |
| Other Current Assets | $237.35M |
| Noncurrent Assets | $123.61M |
| Fixed Assets | $1.22M |
| Other Non-current Assets | $122.39M |
| Liabilities | $343.96M |
| Current Liabilities | $162.94M |
| Accounts Payable | $21.19M |
| Wages | $11.02M |
| Other Current Liabilities | $130.74M |
| Noncurrent Liabilities | $181.02M |
| Long-term Debt | $48.25M |
| Other Non-current Liabilities | $132.77M |
| Equity | $32.61M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $32.61M |
| Liabilities And Equity | $376.57M |
| Net Cash Flow From Operating Activities | $67.99M |
| Net Cash Flow From Operating Activities, Continuing | $67.99M |
| Net Cash Flow From Investing Activities | -$7.93M |
| Net Cash Flow From Investing Activities, Continuing | -$7.93M |
| Net Cash Flow From Financing Activities | $72.93M |
| Net Cash Flow From Financing Activities, Continuing | $72.93M |
| Net Cash Flow | $132.99M |
| Net Cash Flow, Continuing | $132.99M |
| Comprehensive Income/Loss | -$5.35M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$5.35M |
| Other Comprehensive Income/Loss | -$5.35M |